Table 6.
Study | Number of patients | Followup (months) | Infection rate | Instability rate |
---|---|---|---|---|
Valenti et al. [16] | 39 | 84 | 5% | NR |
Sirveaux et al. [14] | 80 | 45 | 1% | 5% |
Rittmeister et al. [13] | 8 | 54 | 13% | NR |
Boulahia et al. [2] | 16 | 35 | NR | 6% |
De Wilde et al. [4] | 13 | 36 | 15% | 31% |
Sirveaux et al. [15] | 80 | 44 | 1% | 9% |
Boileau et al. [1] | 45 | 40 | 4% | NR |
Werner et al. [18] | 58 | 38 | 3% | 9% |
Frankle et al. [6] | 60 | 33 | 3% | 2% |
Guery et al. [9] | 66 | 70 | 5% | 3% |
Levy et al. [10] | 29 | 35 | 3% | 14% |
Wall et al. [17] | 199 | 24 | 4% | 8% |
Wierks et al. [19] | 20 | 9 | 5% | 10% |
Trappey et al. | 284 | 24 | 3% | 6% |
NR = not reported